Related Experiment Videos
Phenylketonuria: diet for life or not?
R Cerone1, M C Schiaffino, S Di Stefano
1Department of Pediatrics, G. Gaslini Institute, University of Genova, Genoa, Italy.
Acta Paediatrica (Oslo, Norway : 1992)
|July 27, 1999
Summary
Phenylketonuria (PKU) patients off diet showed neurological abnormalities despite normal IQ. Lifelong dietary management is recommended, with slightly relaxed phenylalanine levels for adults.
Area of Science:
- Metabolic disorders
- Neuroscience
- Dietary management
Background:
- Phenylketonuria (PKU) is a genetic disorder requiring lifelong dietary management.
- The necessity of maintaining a restricted phenylalanine diet into adulthood for PKU patients is debated.
- Previous studies focused on cognitive outcomes, with less emphasis on neurological signs in adults off diet.
Purpose of the Study:
- To evaluate the long-term effects of discontinuing a restricted phenylalanine diet in early-treated PKU patients.
- To assess neurological, cognitive, and neurophysiological status in adult PKU patients after diet cessation.
- To inform recommendations regarding lifelong dietary management in PKU.
Main Methods:
- Neurological examination
- Intelligence Quotient (IQ) testing
- Neurophysiological assessments
- Magnetic Resonance Imaging (MRI) of the brain
Main Results:
- All 16 early-treated PKU patients who discontinued their diet showed abnormal neurological signs.
- Intelligence Quotient (IQ) and electrophysiological studies remained normal or unchanged compared to pre-discontinuation results.
- Brain MRI findings were not detailed but implied in the overall assessment.
Conclusions:
- A restricted phenylalanine diet should be continued throughout adult life for PKU patients.
- Slightly higher phenylalanine levels (<10 mg/dL or <600 micromol/L) may be permissible in adulthood compared to childhood.
- Lifelong dietary adherence is crucial for preventing neurological deterioration in PKU.